Indications of Intravenous Immunoglobulin Use

    Basic Details
    Date Posted
    Friday, May 20, 2016
    Status
    Complete
    Medical Product
    intravenous immunoglobulin (IVIg)
    Description

    Modular program-based one-time assessment of the indications for use of intravenous immunoglobulin products. The query was run against the Mini-Sentinel Distributed Database (MSDD) for the time period of January 1, 2006 to June 30, 2012.  Modular programs are adaptable standardized programs. Results were generated using Modular Program 7; click here for more information.  Queries were distributed in February 2013. This report includes data from 18 Data Partners.
     
    If you are using a web page screen reader and are unable to access this document, please use the Contact Us page for assistance or send an email requesting assistance to info@sentinelsystem.org.
     
    The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

    Additional Details
    FDA Center
    CDER
    Time Period
    January 1, 2006 -July 30, 2012
    Study Type
    Modular Program
    Assessment Type
    Exploratory Analyses
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)